Could immune cells in fat hold the key to Obesity-Related diseases?

NCT ID NCT06335771

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study investigates how immune cells in fat tissue, called macrophages, handle fats and whether this affects metabolism in people with obesity. Researchers will compare adults with obesity and type 2 diabetes or fatty liver to lean individuals, using imaging, blood tests, and tissue samples. Participants with obesity will also receive dietary counseling to lose 10% of their body weight, allowing researchers to see how weight loss changes these cellular processes. The goal is to better understand why some people with obesity develop metabolic problems, which could lead to new prevention or treatment strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dietary consultation weight loss intervention
What this could lead to
If successful, this research could reveal new targets for treating obesity-related conditions like type 2 diabetes and fatty liver disease.
What could go wrong
This is an early-stage observational and interventional study with a small number of participants, so findings may not apply broadly or lead to immediate treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Missouri School of Medicine

    RECRUITING

    Columbia, Missouri, 65212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.